$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61M-035/00
  • A61M-005/142
  • A61K-031/135
  • A61K-031/17
  • A61K-031/192
  • A61K-031/27
  • A61K-031/4164
  • A61K-031/42
  • A61K-031/428
  • A61K-031/435
  • A61K-031/4436
  • A61K-031/445
  • A61K-031/47
  • A61K-031/498
  • A61K-031/505
  • A61K-031/55
  • A61K-031/704
  • A61M-037/00
  • A61N-001/30
  • A61K-031/137
  • A61K-031/155
  • A61K-031/165
  • A61K-031/415
  • A61K-031/4439
  • A61K-031/473
  • A61K-031/4965
  • A61K-031/7072
  • A61K-031/708
  • A61K-009/00
  • A61K-009/70
  • A61K-031/4468
  • A61M-039/22
  • A61K-031/04
  • A61K-031/13
  • A61K-031/18
  • A61K-031/195
  • A61K-031/198
  • A61K-031/216
  • A61K-031/404
  • A61K-031/405
  • A61K-031/4168
  • A61K-031/421
  • A61K-031/4453
  • A61K-031/4458
  • A61K-031/465
  • A61K-031/485
  • A61K-031/4985
출원번호 US-0494392 (2017-04-21)
등록번호 US-10258738 (2019-04-16)
발명자 / 주소
  • DiPierro, Guy
  • Giannos, Steven A.
출원인 / 주소
  • Chrono Therapeutics Inc.
대리인 / 주소
    Shay Glenn LLP
인용정보 피인용 횟수 : 0  인용 특허 : 208

초록

Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, Alzheimer's disease, sleep disorders, Parkinson's disease, Attention Deficit Disorder and nicotine addiction involve synchronizing and t

대표청구항

1. A method for treating a human with Parkinson's disease comprising: delivering an active pharmaceutical ingredient (API) for treating Parkinson's disease, symptoms associated with Parkinson's disease, or symptoms associated with treatments for Parkinson's disease dissolved in a solvent to a skin-i

이 특허에 인용된 특허 (208)

  1. Lee Eun S. (Redwood City CA) Goetz Victor (Philadelphia PA), Abusable substance dosage form having reduced abuse potential.
  2. Anderson, Carter R.; Morris, Russell L., Abuse potential reduction in abusable substance dosage form.
  3. Hart,John R.; Stebbings,Deanna L., Abuse-resistant transdermal dosage form.
  4. Nelson, Kyle S.; Bischoff, Brian J., Activity monitoring.
  5. Carroll Gary T. (Boulder CO) Pilmanis George J. (Boulder CO) Stinton Vincent D. (Littleton CO), Adaptable electronic monitoring and identification system.
  6. Thomas O. Murdock, Anhydrous drug reservoir for electrolytic transdermal delivery device.
  7. Le Foyer de Costil, Carol; Ayache, Liliane; Tisseyre, Jean-Paul, Anti-acne composition.
  8. Kushnir, Moshe; Heldman, Eliahu, Apparatus for the transdermal treatment of Parkinson's disease.
  9. Bro William L. (8939 S. Sepulveda #530 Los Angeles CA 90045), Automated and interactive behavioral and medical guidance system.
  10. Sternberg Edward A. ; de Faber Jan-Tjeerd H. N.,NLX, Bandage including data acquisition components.
  11. DiPierro, Guy; Giannos, Steven A., Biosynchronous transdermal drug delivery.
  12. Dipierro, Guy, Biosynchronous transdermal drug delivery.
  13. DiPierro, Guy; Giannos, Steven A., Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like.
  14. DiPierro, Guy; Giannos, Steven A., Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like.
  15. Dipierro, Guy; Giannos, Steven A., Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like.
  16. Rolf David, Compliance verification method and device in compulsory drug administration.
  17. Ferber Richard H. (St. Paul MN) Burton Scott A. (St. Paul MN), Composition for transdermal penetration of medicaments.
  18. Jones Richard L. (Edmonton CAX), Composition to help stop smoking.
  19. Kanios, David P.; Hartwig, Rod; Mantelle, Juan A.; Houze, David W., Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems.
  20. Kanios, David; Hartwig, Rod, Compositions and methods for delivering active agents in transdermal drug delivery systems.
  21. Kanios, David, Compositions and methods to effect the release profile in the transdermal administration of active agents.
  22. Nagy Christa F. (Wyckoff NJ) Quick Timothy W. (Clifton NJ) Shapiro Stanley S. (Livingston NJ), Compositions of retinoic acids and tocopherol for prevention of dermatitis.
  23. Ghita Lanzendorfer DE; Franz Stab DE; Sven Untiedt DE, Cosmetic and dermatological preparations with flavonoids.
  24. Castro John R. (Stamford CT), Cosmetic compositions.
  25. Herstein Morris (P.O. Box 209 Scarsdale NY 10583), Cosmetic skin-renewal-stimulating composition with long-term irritation control.
  26. Weyer, Grant; Trickey, Simon Robert Sanford; Rose, Timothy Donald, Delivery system for remote treatment of an animal.
  27. Kydonieus, Agis; Conway, Robert G.; Rossi, Thomas M., Dermal delivery device.
  28. Hall Bonnie J. (Mason OH) Baur Julie A. (Fairfield OH) Deckner George E. (Cincinnati OH), Dermatological compositions and method of treatment of skin lesions therewith using benzoyl peroxide and tocopherol este.
  29. Yodfat, Ofer; Perlman, Danna, Detachable portable infusion device.
  30. Rush, Benjamin M.; Reggiardo, Christopher V., Device and method employing shape memory alloy.
  31. Haak Ronald P. ; Gyory J. Richard ; Theeuwes Felix, Device and method of iontophoretic drug delivery.
  32. Fallon Renee A. (Sunnyvale CA) Wilson Donald R. (San Francisco CA), Device for administering drug transdermally which provides an initial pulse of drug.
  33. Fallon Renee A. ; Wilson Donald R. ; Beste Russell D., Device for administering drug transdermally with a controlled temporal change in skin flux.
  34. Strausak Sabina (Basel CHX) Leuenberger Hans (Pfeffingen CHX), Device for delivering a medicament.
  35. Borg Charles,CAX ITX M5J 2L1, Device to facilitate alternative response behavior.
  36. Edwards, Evan T.; Edwards, Eric S.; Licata, Mark J., Devices, systems, and methods for medicament delivery.
  37. Imoto, Masahiro; Iwanami, Tatsuya; Akabane, Minako; Tani, Yoshihiro, Di-substituted imineheterocyclic compounds.
  38. Sibalis Dan (Stony Brook NY), Disposable and/or replenishable transdermal drug applicators and method of manufacturing same.
  39. Campbell, Patricia S.; Chandrasekaran, Santosh K., Dosage for coadministering drug and percutaneous absorption enhancer.
  40. Gross, Joseph; Tsals, Izrail; Lavi, Gilad; Yigal, Gil; Carmel, Ehoud, Drug delivery device.
  41. Shekalim, Avraham, Drug delivery device and method.
  42. Johnston, Raymond P.; Scholz, Matthew T.; Heinecke, Steven B.; Hentzen, Charles A., Drug delivery dressing having fluid control film.
  43. Ramirez, Jose E.; McNamara, Austin; Hattendorf, Judy; Goldner, Steve, Drug delivery system.
  44. Potter, David Stuart; Potter, Charles David Ogilvy, Drug delivery technology.
  45. Choi, Young Kweon; Yu, Hyun Suk; Yoon, Hye Jeong; Kim, Ho Chin, Dual adhesive transdermal drug delivery system.
  46. Clendenon, John Richard, Electronic behavior modification reminder system and method.
  47. D\Angelo Joseph P. (Miami FL) Schur Henry (Miami FL), Electronic transdermal drug delivery system.
  48. Lattin Gary A. (Forest Lake MN) Dickson Dale A. (Fridley MN) Grace Michael J. (Coon Rapids MN), Electrotransport agent delivery device having a disposable component and a removable liner.
  49. McNichols Larry A. (Coon Rapids MN) Badzinski John D. (Coon Rapids MN) Haak Ronald P. (Menlo Park CA), Electrotransport delivery device.
  50. Meconi Reinhold,DEX ; Seibertz Frank,DEX, Estradiol penetration enhancers.
  51. Morita,Toshio; Inoue,Hitoshi; Nishimura,Kunio; Suhara,Yutaka; Ohshima,Satoshi; Yumura,Motoo, Fine carbon fiber, method for producing the same and electrically conducting material comprising the fine carbon fiber.
  52. Joshi Ashok V. ; Davis James O. ; Wold Truman ; di Palma Giorgio, Fluid delivery apparatus and method.
  53. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M, Gastric retained gabapentin dosage form.
  54. Shell John W. ; Louie-Helm Jenny, Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter.
  55. Perlman,Neil; Mapes Riordan,Daniel, Habit cessation aide.
  56. Orr,Kevin H.; Mankaruse,George S.; Asaria,Ali, Handheld electronic device including vibrator having different vibration intensities and method for vibrating a handheld electronic device.
  57. Tran, Bao, Health monitoring appliance.
  58. Tran, Bao, Health monitoring system.
  59. Klug Reja B. (30 Bay Dr. SE. Fort Walton Beach FL 32548) Ford Richard D. (117 Lake Lorraine Cir. Shalimar FL 32579) Jamison Keith A. (137 Indian Bayou Dr. Destin FL 32541) Stearns Ronald E. (2 Caswel, High energy coaxial cable for use in pulsed high energy systems.
  60. Behar Albert (Reston VA) Behar Orna (Reston VA) Frederiksen Lee W. (McLean VA) Howard-Link Donald A. (Columbia MD) Timmerman Catherine (Washington DC), Human behavior modification which establishes and generates a user adaptive withdrawal schedule.
  61. Scholz Matthew T. ; Asmus Robert A. ; Hedenstrom John C., Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents.
  62. Frate Dean M. ; Chiarelli Joseph A. ; Ma Yong, Hydrogels containing substances.
  63. Amkraut Alfred (Palo Alto CA), Inducing skin tolerance to a sensitizing drug.
  64. Tucholski, Gary R.; Allison, Leonard Blaine, Integrated electronic device and methods of making the same.
  65. Rhodes John,GBX ; Evans Brian K.,GBX ; Rhodes Peter,GBX ; Sandborn William J., Intestinal absorption of nicotine to treat nicotine responsive conditions.
  66. Gross Joseph,IEX ; Kelly John Gerard,IEX, Intradermal drug delivery device.
  67. Flower Ronald J. (Vernon NJ), Iontophoretic drug delivery device having an improved controller.
  68. Flower Ronald J., Iontophoretic drug delivery device having improved controller.
  69. Guerrera Stephen K. ; Bernhard Michael I., Iontophoretic drug delivery system, including method for activating same for attachment to patient.
  70. Stropkay Scott Edward ; Bernhard Michael I., Iontophoretic drug delivery system, including unit for dispensing patches.
  71. Dinh Steven Minh ; Singh Parminder Bobby ; Comfort Ann Reese, Iontophoretic transdermal delivery and control of adverse side-effects.
  72. Hermelin Victor M., Maximizing effectiveness of substances used to improve health and well being.
  73. Edwards, Eric S.; Edwards, Evan T.; Licata, Mark J.; Meyers, Paul F.; Weinzierl, David A., Medicament delivery device having an electronic circuit system.
  74. Woias Peter,DEX ; Richter Martin,DEX, Medicament dosing system.
  75. Rose Jed E. (907 Kimball Dr. Durham NC 27705) Jarvik Murray E. (2001 Georgina Avenue Santa Monica CA 90402) Rose Karce D. (4050 W. Soda Rock Dr. Healdsburg CA 95448), Method and apparatus for aiding in the reduction of incidence of tobacco smoking.
  76. Rose Jed E. (Venice CA) Jarvik Murray E. (Santa Monica CA) Rose Karce D. (Healdsburg CA), Method and apparatus for aiding in the reduction of incidence of tobacco smoking.
  77. Valcke Christian P. ; Bochenko Walter J. ; Hillman Robert S., Method and apparatus for closed loop drug delivery.
  78. Lutz Raymond, Method and device for modifying behavior.
  79. Segel Joseph M. ; Samuelson Michael H., Method and system for stopping or modifying undesirable health-related behavior habits or maintaining desirable health-.
  80. Bro L. William, Method for mediating social and behavioral processes in medicine and business through an interactive telecommunications.
  81. Becher,Frank; Klink,Ann Katrin, Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system.
  82. Phipps J. Bradley (Plymouth MN), Method for reducing sensation in iontophoretic drug delivery.
  83. Cormier Michel J. N. (Palo Alto CA) Ledger Philip W. (Mountain View CA) Amkraut Alfred (Palo Alto CA) Marty Jean P. (Sceaux FRX), Method for reducing sensitization or irritation in transdermal drug delivery and means therefor.
  84. Van de Casteele, Russell, Method for the delivery of a biologically active agent.
  85. Caldwel William S. (Winston-Salem NC) Lippiello Patrick M. (Lewisville NC), Method for treatment of neurodegenerative diseases.
  86. Caldwell William S. (Winston-Salem NC) Lippiello Patrick M. (Clemmons NC), Method for treatment of neurodegenerative diseases.
  87. Caldwell William S. (Winston-Salem NC) Lippiello Patrick M. (Clemmons NC), Method for treatment of neurodegenerative diseases.
  88. Lippiello Patrick M. (Clemmons NC) Caldwell William S. (Winston-Salem NC), Method for treatment of neurodegenerative diseases.
  89. Lippiello Patrick M. (Clemmons NC) Caldwell William S. (Winston-Salem NC), Method for treatment of neurodegenerative diseases.
  90. Majeed, Muhammed; Badmaev, Vladimir; Bammi, Rajinder Kumar; Prakash, Subbalakshmi; Natarajan, Sankaran, Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives.
  91. Alliger Howard (10 Ponderosa Dr. Melville NY 11747), Method of treating small mouth ulcers with lactic acid.
  92. Masterson Joseph G. (Dublin IEX), Method of using nicotine in the treatment of conditions susceptible to said treatment.
  93. Quik, Maryka; Di Monte, Donato; Langston, J. William, Methods and compositions for reduction of side effects of therapeutic treatments.
  94. Koo, John; Shudo, Jutaro; Shirai, Sadanobu, Methods of administering a dermatological agent to a subject.
  95. Caldwell William Scott ; Dull Gary Maurice ; Bencherif Merouane ; Lippiello Patrick Michael, Methods of treating central nervous system disorders with aryl substituted olefinic amine compounds.
  96. Lewy Alfred J. (Portland OR) Sack Robert L. (Portland OR), Methods of treating circadian rhythm disorders.
  97. Granger Colin D. (Chester NJ) Simon Thomas H. (Morris Plains NJ), Misuse-resistive transdermal opioid dosage form.
  98. Brandt, Derek; Calasso, Irio, Modular drug delivery device for administering discrete doses of a medicament.
  99. Batz Hans-Georg,DEX, Monitoring system for the regular intake of a medicament.
  100. D'Angelo Joseph P. ; Schur Henry, Multidose transdermal drug delivery system.
  101. Audett, Jay Douglas, Multilaminate backing construction.
  102. Jacobsen Stephen C. ; Wyatt Roland ; Peterson Stephen C. ; Petelenz Tomasz J., Multipathway electronically-controlled drug delivery system.
  103. Byland, Timothy D.; Collins, James Matthew; Fisher, Mark James; Grimley, John; Mojarrad, Mehran; O'Fallon, John Michael; Sampson, Craig Field; Tappel, James G., Needle-free injection device.
  104. Edwards ; III William B. (Richmond VA), Nicotine analogs.
  105. Sanberg Paul R. ; Shytle Roland D. ; Silver Archie A., Nicotine antagonists for nicotine-responsive neuropsychiatric disorders.
  106. Dam Anders (Sollerod Park 16-St. 3 DK-2840 Holte DKX), Nicotine containing stimulant unit.
  107. Cooke, John; Jang, James; Tsao, Phillip; Heeschen, Christopher, Nicotine in therapeutic angiogenesis and vasculogenesis.
  108. Santus Gian Carlo (Milan ITX), Nicotine lozenge and therapeutic method for smoking cessation.
  109. Edwards ; III William B. (Richmond VA), Optically active nicotine analogs and process for their preparation.
  110. Gusler, Gloria; Berner, Bret; Chau, Mei; Padua, Aimee, Optimal polymer mixtures for gastric retentive tablets.
  111. Wright, IV,Curtis; Carpanzano,Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  112. John M. Siebert ; Rajendra K. Khankari ; Unchalee Kositprapa ; S. Indiran Pather, Orally disintegrable tablet forming a viscous slurry.
  113. Rajendra K. Khankari ; John Hontz ; Sara J. Chastain, Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet.
  114. Cortese Richard (San Jose CA) Theeuwes Felix (Los Altos CA), Osmotic device with hydrogel driving member.
  115. Kamen, Dean; Gray, Larry B.; Beavis, Russell H., Patch-sized fluid delivery systems and methods.
  116. Mak, Vivien H. W.; Grayson, Stephen, Penetration enhancing and irritation reducing systems.
  117. Clark,Paul T.; Moore,Margaret A., Personal coaching system for clients with ongoing concerns such as weight loss.
  118. Tapolsky, Gilles H.; Osborne, David W., Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces.
  119. Dull Gary Maurice ; Wagner Jared Miller ; Caldwell William Scott ; Miller Craig Harrison ; Schmitt Jeffrey Daniel ; Bhatti Balwinder Singh ; Hadimani Srishailkumar Basawannappa, Pharmaceutical compositions and methods for use.
  120. Gary Maurice Dull ; Craig Harrison Miller ; William Scott Caldwell ; Srishailkumar Basawannappa Hadimani, Pharmaceutical compositions and methods for use.
  121. Peter Anthony Crooks ; Haeil Park KR; Balwinder Singh Bhatti ; William Scott Caldwell ; Gary Maurice Dull, Pharmaceutical compositions and methods for use.
  122. Sackler,Richard, Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant.
  123. Huang, Joseph Zhili; DiPierro, Guy, Portable drug delivery device including a detachable and replaceable administration or dosing element.
  124. Huang, Joseph Zhili; DiPierro, Guy, Portable drug delivery device including a detachable and replaceable administration or dosing element.
  125. Harpal S. Kumar GB; Paul Johnson GB; Michael D. Llewellyn GB; William J. Mullarkey GB; William New, Jr. ; Laurence J. Nicolson GB; William G. O'Brien GB; John D. Place GB; Peter M. Relph GB, Portable remote patient telemonitoring system.
  126. Pete Ferguson GB; Harpal Kumar GB; Graham Lay GB; Mike Llewellyn GB; John D. Place GB, Portable remote patient telemonitoring system using a memory card or smart card.
  127. Gurley,David; Rosamond,James, Positive modulators of nicotinic receptor agonists.
  128. Roberts Josephine A. (7509 Ben Avon Rd. Bethesda MD 20817) Burwell Jephthae W. (3119 Adams Mill Rd. ; NW. Washington DC 20010), Positive-pressure ventilator system with controlled access for nebulizer component servicing.
  129. Amkraut Alfred (Palo Alto CA) Shaw Jane E. (Atherton CA), Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug.
  130. Skrabal, Falko, Process for determining parameters of interest in living organisms.
  131. Chavdarian Charles G. (Richmond VA) Sanders Edward B. (Richmond VA), Process for the preparation of optically active nicotine analogs.
  132. Shennib, Adnan, Programmable ECG sensor patch.
  133. Henley Julian L. (330 Orchard St. New Haven CT 06511-4417), Programmable apparatus for the transdermal delivery of drugs and method.
  134. Sibalis Dan ; Rosen Sanford, Programmable control and mounting system for transdermal drug applicator.
  135. Bettinger, David S., Programmable transdermal therapeutic apparatus.
  136. Wong Patrick S. L. ; Dong Liang-Chang ; Edgren David E. ; Theeuwes Felix ; Gardner Phyllis I. ; Jao Francisco ; Wan Jason J., Prolonged release active agent dosage form adapted for gastric retention.
  137. Hansted, Kenneth W.; Sanders, David; Welsher, Philip, Promotional simulation for transdermal patch sampler.
  138. Wille John J., Prophylactic and therapeutic treatment of skin sensitization and irritation.
  139. Wille John J. (Trenton NJ) Kydonieus Agis (Kendall Park NJ), Prophylactic and therapeutic treatment of skin sensitization and irritation.
  140. Wille John J. (Trenton NJ) Kydonieus Agis (Kendall Park NJ) Castellana Frank S. (Princeton NJ), Prophylactic treatment of allergic contact dermatitis.
  141. Sibalis Dan (Stony Brook NY), Pulsating transdermal drug delivery system.
  142. Tucholski, Gary R., RFID antenna-battery assembly and the method to make the same.
  143. Cherukuri,S. Rao, Rapid-melt compositions methods of making same and methods of using same.
  144. Grimshaw,Michael N.; Barbieri,Donald J.; Vizzini,Louise M.; Marsh,Steve F., Rapidly disintegrable tablets.
  145. Khankari Rajendra K. ; Hontz John ; Chastain Sara J. ; Katzner Leo, Rapidly dissolving robust dosage form.
  146. Yodfat, Ofer; Kaidar, Ruthy; Shapira, Gali, Reciprocating delivery of fluids to the body with analyte concentration monitoring.
  147. Ledger Philip W. (Mountain View CA) Cormier Michel J. (Mountain View CA) Amkraut Alfred (Palo Alto CA), Reduction or prevention of sensitization to drugs.
  148. Cormier Michel J-N (Mountain View CA) Ledger Philip W. (Mountain View CA) Amkraut Alfred (Palo Alto CA), Reduction or prevention of skin irritation by drugs.
  149. Cormier Michel (Mountain View CA) Amkraut Alfred (Palo Alto CA) Ledger Philip W. (Bedford GBX), Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensiti.
  150. Marchitto, Kevin S.; Flock, Stephen T., Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy.
  151. Bassuk, William K.; Hughes, Ralph S.; Birdwell, Vince E., Remote controlled transdermal medication delivery device.
  152. Faust Mark Henry ; Johnson Jay Gregory, Reusable cassette housings and methods.
  153. Lattin Gary A. ; Belden Tighe M. ; Withell Andrew J.,NZX, Self-contained transdermal drug delivery device.
  154. Tapper Robert, Sensor controlled analysis and therapeutic delivery system.
  155. Loubert, Gary Lee; Menjoulet, Tiffany Anne; Mitchell, Timothy Paul; Thomas, Xavier Jean-Paul, Silicone acrylate hybrid composition and method of making same.
  156. Lee Eun Soo ; Yum Su Il, Skin permeation enhancer compositions using acyl lactylates.
  157. Carlsson Thommy (Helsingborg SEX) Andersson Sven B. (dakra SEX), Smoking substitute.
  158. Fern Ove B. (Helsingborg SEX) Helgertz Stig K. A. (Helsingborg SEX) Ohlsson Corfitz B. I. (Helsingborg SEX), Smoking substitutes for nasal administration-I.
  159. Westman Eric C. ; Rose Jed E. ; Tomlin Keith F., Solution containing nicotine.
  160. Dorman Frank D. (Minneapolis MN) Buchwald Henry (Minneapolis MN), Spring driven infusion pump.
  161. Osborne James L. (Mountain View CA) Nelson Melinda (Sunnyvale CA) Enscore David J. (Saratoga CA) Yum Su I. (Los Altos CA) Gale Robert M. (Los Altos CA), Subsaturated nicotine transdermal therapeutic system.
  162. Franz Michel R. (Brussels BEX) Oth Marianne P. (Brussels BEX), Sustained release, bilayer buoyant dosage form.
  163. Simon, David Lew, Sustained-release nalmefene preparations and method.
  164. Farr, Stephen J., System for effecting smoking cessation.
  165. Walker, Jay S.; Jorasch, James A.; Nee, Jr., Patrick W.; Fincham, Carson C. K.; Walker, Evan; Bean, David; Maniam, Rajivan, Systems and methods for improved health care compliance.
  166. Currie, John F.; Paranjape, Makarand; Peck, Carl C.; White, Robert; Schneider, Thomas W., Systems and methods for monitoring health and delivering drugs transdermally.
  167. Abreu, Osvaldo, Tamper resistant dosage form comprising an adsorbent and an adverse agent.
  168. Giannos Steven Andrew ; Dinh Steven Minh ; Berner Bret, Temporally controlled drug delivery systems.
  169. Tucholski, Gary R., Thin printable electrochemical cell and methods of making the same.
  170. Wright, IV, Curtis, Titratable dosage transdermal delivery system.
  171. Shaw Alec S. W. (Birch House ; Off Crimbles Lane Cockerham ; Lancashire GB2), Tobacco product.
  172. Gale, Robert M.; Stein, Thomas M.; Audett, Jay; Stepic, Jane; Phipps, Joseph B.; Cormier, Michel J. N., Transdermal analgesic systems with reduced abuse potential.
  173. Haak Ronald P. (Menlo Park CA) Theeuwes Felix (Los Altos Hills CA) Gyory J. Richard (San Jose CA) Lattin Gary A. (Forest Lake MN), Transdermal delivery device.
  174. Flanigan, Peggy-Jean P.; Choi, Hye-ok, Transdermal delivery devices.
  175. Govil Sharad K. (Plantation FL) Kohlman Paul (Deerfield Beach FL), Transdermal delivery of nicotine.
  176. Stinchcomb, Audra L.; Swaan, Peter W., Transdermal delivery of opioid antagonist prodrugs.
  177. Yum, Su II; Kwon, Sung Yun; Song, Xiaoping; Brown, James E., Transdermal delivery systems.
  178. Sibalis Dan (Stony Brook NY), Transdermal drug applicator.
  179. Lee Eun S. (Redwood City CA) Edgren David (El Granada CA) Yum Su I. (Los Altos CA), Transdermal drug delivery device.
  180. Bello Gastone P. (Monmouth Beach NJ) Lyle John W. (Belmar NJ) Johnson Donald A. (Sea Girt NJ), Transdermal drug delivery device and method for its manufacture.
  181. Kanios, David; Mantelle, Juan A.; Nguyen, Viet, Transdermal drug delivery device including an occlusive backing.
  182. Watanabe, Tyler; Gale, Robert M., Transdermal drug delivery device package with improved drug stability.
  183. Fallon Renee A. (Sunnyvale CA) Venkatraman Subbu S. (Palo Alto CA) Cleary Gary W. (San Mateo CA), Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset.
  184. Venktrama Subbu S. (Palo Alto CA) Fallon Renee A. (Sunnyvale CA) Cleary Gary W. (San Mateo CA), Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset.
  185. Zumbrunn, Werner; Imanidis, Georgios; DiPierro, Guy; van De Venn, Hans Wernher, Transdermal drug delivery method and system.
  186. Zumbrunn, Werner; Imanidis, Georgios; Dipierro, Guy; Van De Venn, Hans Werner, Transdermal drug delivery method and system.
  187. Zumbrunn, Werner; Van de Venn, Hans Werner; Imanidis, George; DiPierro, Guy, Transdermal drug delivery method and system.
  188. Valia, Kirti H; Ramaraju, Vatsala S, Transdermal methods and systems for treating Alzheimer's disease.
  189. Govil Sharad K. (Plantation FL) Rudnic Edward M. (Boca Raton FL) Sterner Dale G. (Pembroke Pines FL), Transdermal nitroglycerin patch with penetration enhancers.
  190. Peck James V. (10821 Millington La. Richmond VA 23233) Minaskanian Gevork (11701 Lockport Ter. Richmond VA 23233), Transdermal penetration enhancers.
  191. Pal Svedman SE, Transdermal perfusion of fluids.
  192. Hille,Thomas; Deurer,Lothar, Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience.
  193. Müller, Walter; Leonhard, Johannes, Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer.
  194. Hille, Thomas; Horstmann, Michael; Mueller, Walter, Transdermal therapeutic system for administering the active substance buprenorphine.
  195. Horstmann, Michael; Koch, Andreas, Transdermal therapeutic system reinforced by ultrasounds.
  196. Horstmann, Michael; Mueller, Walter, Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy.
  197. Wille John J. ; Kydonieus Agis F., Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity.
  198. Stinchcomb, Audra Lynn; Golinski, Miroslaw Jerzy; Hammell, Dana Carmel; Howard, Jeffrey Lynn, Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs.
  199. Finn, Andrew; Vasisht, Niraj, Transmucosal delivery devices with enhanced uptake.
  200. Korneyev, Alexander Y., Treating open skin lesions using extract of sea buckthorn.
  201. Fisher Gary R. (2251 Federal Ave. Los Angeles CA 90064), Treatment device to aid in long-term cessation of smoking.
  202. Nicholas V. Perricone, Treatment of skin damage using olive oil polyphenols.
  203. Quan Danyi (Salt Lake City UT) Deshpanday Ninad A. (Salt Lake City UT) Venkateshwaran Srinivasan (Salt Lake City UT) Ebert Charles D. (Salt Lake City UT), Triacetin as a penetration enhancer for transdermal delivery of a basic drug.
  204. Duffy John A. (West Milford NJ), Use of ascorbic acid to reduce irritation of topically applied active ingredients.
  205. Kang, Sewon; Fisher, Gary J.; Voorhees, John J., Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor.
  206. Cesaro, Pierre; Villafane, Gabriel, Use of nicotine or its derivatives in a drug for treating neurological disease, in particular Parkinson's disease.
  207. Heiber Werner (Bedford Hills NY) Andriola Robert (Putnam Valley NY) Williams Paul (Fairlawn NJ) Ebert Charles (Redwood City CA), User-activated transdermal therapeutic system.
  208. Connelly, Robert I.; Shermer, Charles D.; Powell, Kenneth G., Wearable, self-contained drug infusion device.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트